Seronegative Myasthenia Plasmas and Non‐IgG Fractions Transiently Inhibit nAChR Functiona
- 1 May 1998
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 841 (1) , 501-504
- https://doi.org/10.1111/j.1749-6632.1998.tb10970.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Seronegative myasthenia gravisNeurology, 1997
- Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the ε subunitNeuroscience Letters, 1996
- Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravisJournal of Neuroimmunology, 1996
- Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell linePflügers Archiv - European Journal of Physiology, 1994
- Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor FunctionaAnnals of the New York Academy of Sciences, 1993
- Seronegative myasthenia gravis: A plasma factor inhibiting agonist‐induced acetylcholine receptor function copurifies with IgMAnnals of Neurology, 1991
- A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitroMuscle & Nerve, 1990
- Protein Phosphorylation of Nicotinic Acetylcholine ReceptorCritical Reviews in Biochemistry and Molecular Biology, 1989
- MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITYThe Lancet, 1986
- Diaphragmatic myasthenia in mother and childPostgraduate Medical Journal, 1985